How late is too late for treatment?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36749315.
- Also identified by DOI 10.7554/eLife.86117 and PMC identifier 9904755.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Experiments on mice suggest that an approach called antisense oligonucleotide therapy may be able to treat some symptoms of Angelman syndrome, including problems with epilepsy and sleep.
Medical subject headings
- Angelman Syndrome
- Epilepsy